A Bhardwaj Selected Research

LY 231617

1/2000

Antioxidant LY231617 enhances electrophysiologic recovery after global cerebral ischemia in dogs.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

A Bhardwaj Research Topics

Disease

5	Ischemia 08/2001 - 01/2000
5	Infarction (Infarctions) 08/2001 - 01/2000
5	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 08/2001 - 03/2000
4	Stroke (Strokes) 08/2001 - 01/2000
4	Brain Ischemia (Cerebral Ischemia) 04/2000 - 01/2000
2	Neoplasm Metastasis (Metastasis) 05/2015 - 04/2014
2	Brain Injuries (Brain Injury) 08/2001 - 01/2000
2	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 03/2000 - 02/2000
1	Tachycardia (Tachyarrhythmias) 01/2022
1	Ventricular Fibrillation 01/2022
1	Heart Arrest (Cardiac Arrest) 01/2022
1	Melanoma (Melanoma, Malignant) 05/2015
1	Prostatic Neoplasms (Prostate Cancer) 04/2014
1	Pancreatic Neoplasms (Pancreatic Cancer) 11/2010
1	Venous Thromboembolism 09/2010
1	Atrial Fibrillation 07/2010
1	Bacterial Infections (Bacterial Infection) 10/2008
1	Carcinogenesis 06/2002
1	Lung Neoplasms (Lung Cancer) 04/2002
1	Neoplasms (Cancer) 04/2002
1	Lung Diseases (Lung Disease) 04/2002
1	Neurologic Manifestations (Neurological Manifestations) 10/2001
1	Hypertension (High Blood Pressure) 10/2001
1	Oligospermia (Oligozoospermia) 09/2000
1	Azoospermia 09/2000
1	Ischemic Stroke 07/2000
1	Hemorrhage 04/2000
1	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 03/2000
1	Hydrocephalus (Hydrocephaly) 03/2000
1	Hyperemia 01/2000

Drug/Important Bio-Agent (IBA)

3	Halothane (Fluothane)FDA Link 08/2001 - 04/2000
3	triphenyltetrazoliumIBA 07/2001 - 01/2000
2	Pharmaceutical PreparationsIBA 11/2010 - 01/2000
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 09/2010 - 07/2010
2	AntioxidantsIBA 04/2002 - 01/2000
2	LigandsIBA 07/2001 - 04/2000
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 07/2001 - 01/2000
1	Interleukin-8 (Interleukin 8)IBA 05/2015
1	Conditioned Culture MediaIBA 05/2015
1	Protein Isoforms (Isoforms)IBA 04/2014
1	Protein Phosphatase 2 (Protein Phosphatase 2A)IBA 04/2014
1	DNA (Deoxyribonucleic Acid)IBA 11/2010
1	Gemcitabine FDA Link 11/2010
1	CaspasesIBA 11/2010
1	plerixafor FDA Link 11/2010
1	Local Anti-Infective Agents (Antiseptics)IBA 10/2008
1	PhytochemicalsIBA 06/2002
1	CarcinogensIBA 06/2002
1	CatalaseIBA 04/2002
1	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 04/2002
1	Superoxides (Superoxide)IBA 04/2002
1	Superoxide DismutaseIBA 04/2002
1	Glutathione PeroxidaseIBA 04/2002
1	Glucose (Dextrose)FDA LinkGeneric 04/2002
1	SteroidsIBA 10/2001
1	Propofol (Diprivan)FDA LinkGeneric 08/2001
1	Anesthetics (Anesthetic Agents)IBA 08/2001
1	piperidineIBA 07/2001
1	Glutathione (Reduced Glutathione)IBA 09/2000
1	Vitamin E FDA LinkGeneric 09/2000
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 04/2000
1	clazosentanIBA 03/2000
1	Endothelin Receptors (Endothelin Receptor)IBA 03/2000
1	Endothelins (Endothelin)IBA 03/2000
1	Immunoglobulin M (IgM)IBA 03/2000
1	Immunoglobulin A (IgA)IBA 03/2000
1	Complement System Proteins (Complement)IBA 02/2000
1	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 01/2000
1	OxotremorineIBA 01/2000
1	LY 231617IBA 01/2000
1	antineoplaston A10 (A 10)IBA 01/2000
1	Phenol (Carbolic Acid)FDA Link 01/2000
1	Muscarinic AgonistsIBA 01/2000

Therapy/Procedure

4	Therapeutics 11/2010 - 03/2000
1	Resuscitation 01/2022
1	Castration 04/2014
1	Drug Therapy (Chemotherapy) 11/2010
1	Electric Countershock (Cardioversion) 07/2010
1	Anesthesia 10/2001
1	Laminectomy 10/2001
1	Foot Orthoses 08/2001
1	Intravenous Infusions 04/2000
1	Sutures (Suture) 04/2000
1	Duration of Therapy 04/2000
1	Intravenous Administration 04/2000
1	Suture Techniques 01/2000